Analgesics in the US
There are interesting developments in terms of diverging performances within adult systemic analgesics. In 2023, acetaminophen is set to drive current value growth, and significantly outpace the overall performance of adult analgesics. Growth in acetaminophen will be led by brand names such as Tylenol, which is set to experience a stronger performance in 2023, as retailers and suppliers are recovering from supply issues as a result of the “tripledemic” that bombarded consumers in the latter half...
Euromonitor International's Analgesics in USA report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
- Analgesics in the US
- Euromonitor International
- September 2023
- List Of Contents And Tables
- ANALGESICS IN THE US
- KEY DATA FINDINGS
- 2023 DEVELOPMENTS
- Varying performances within adult systemic analgesics
- New vaccine rollout to avoid another “tripledemic”
- Paediatric analgesics continues to post significant growth after a strong 2022
- PROSPECTS AND OPPORTUNITIES
- Growth of topical analgesics/anaesthetic expected to exceed systemic analgesics
- Clean paediatric medicine: Insurgent brands to tackle big players
- Natural pain management on the rise in complement with OTC analgesics
- CATEGORY DATA
- Table 1 Sales of Analgesics by Category: Value 2018-2023
- Table 2 Sales of Analgesics by Category: % Value Growth 2018-2023
- Table 3 NBO Company Shares of Analgesics: % Value 2019-2023
- Table 4 LBN Brand Shares of Analgesics: % Value 2020-2023
- Table 5 Forecast Sales of Analgesics by Category: Value 2023-2028
- Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2023-2028
- CONSUMER HEALTH IN THE US
- EXECUTIVE SUMMARY
- Consumer health in 2023: The big picture
- 2023 key trends
- Competitive landscape
- Retailing developments
- What next for consumer health?
- MARKET INDICATORS
- Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2018-2023
- Table 8 Life Expectancy at Birth 2018-2023
- MARKET DATA
- Table 9 Sales of Consumer Health by Category: Value 2018-2023
- Table 10 Sales of Consumer Health by Category: % Value Growth 2018-2023
- Table 11 NBO Company Shares of Consumer Health: % Value 2019-2023
- Table 12 LBN Brand Shares of Consumer Health: % Value 2020-2023
- Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2018-2023
- Table 14 Distribution of Consumer Health by Format: % Value 2018-2023
- Table 15 Distribution of Consumer Health by Format and Category: % Value 2023
- Table 16 Forecast Sales of Consumer Health by Category: Value 2023-2028
- Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2023-2028
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventive medicine
- Summary 1 OTC: Switches 2022-2023
- Summary 2 Research Sources